Medical Health & Life Science Research News

Hepatitis c segment expected to realize the fastest growth in the global hepatitis drugs market according to new research report

Hepatitis C Segment Expected to Realize the Fastest Growth in the Global Hepatitis Drugs Market During 2015 - 2020 by P&S Market Research.

The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.

Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest growth during the forecast period, with a CAGR of 30.7%.

Explore Report with Detailed TOC on “Global Hepatitis Drugs Market” at: www.psmarketresearch.com/market-an…itis-drugs-market

The increasing incidences of various types of hepatitis, such as hepatitis B, and hepatitis C are playing a pivotal role in the growth of the global hepatitis drugs market. According to the Hepatitis B Foundation, a non-profit organization solely dedicated to the global problem of hepatitis B, approximately 400 million people globally were chronically infected with hepatitis B, as reported at the end of September 2015.

According to the World Health Organization (WHO), an estimated 130 - 150 million people globally were reported to suffer from hepatitis C, as of July 2015. The increasing incidences of hepatitis have increased the demand of therapeutic drugs for the management of diseases.

Report: www.psmarketresearch.com/market-an…ket/report-sample

Geographically, North America dominated the global market of hepatitis drugs in 2014; whereas the Asian market is expected to witness the fastest growth, with a CAGR of 32.4% during the forecast period.

The key companies operating in the global hepatitis drugs market include Gilead Sciences Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co.

Inc., GlaxoSmithKline PLC, AbbVie Inc., Novartis AG, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, and Mitsubishi Tanabe Pharma Corporation.

News From

P&S Market ResearchP&S Market Research
Category: Market Research Publishers and RetailersCompany profile: PS Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries. With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our pub ...

For more information:

Make an Inquiry about this report HERE!
  • www.psmarketresearch.com
  • www.psmarketresearch.com/send-enqu…itis-drugs-market
  • www.facebook.com/psmarketresearch
  • www.linkedin.com/company/p&s-market-research
  • plus.google.com/+Psmarketresearch
  • www.psmarketresearch.com/market-an…itis-drugs-market